For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Invox Pharma Limited

USPTO Granted Patents = 12

EPO Patents = 5

Trademarks = 3

Forward Citations = 4

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Mihriban Tuna (7 out of 14 patents)

Francisca Wollerton (5 out of 5 patents)

Miguel Gaspar (4 out of 6 patents)

4. Jose Munoz-Olaya (4 out of 4 patents)

5. Radhakrishnan P Iyer (3 out of 38 patents)

6. Matthew Lakins (3 out of 3 patents)

7. Katy Louise Everett (2 out of 4 patents)

8. Anjaneyulu Sheri (2 out of 6 patents)

9. Seetharamaiyer Padmanabhan (2 out of 16 patents)

10. Shenghua Zhou (2 out of 9 patents)

11. Sreerupa Challa (2 out of 7 patents)

12. Rayomand H Gimi (2 out of 14 patents)

13. Dillon Cleary (2 out of 2 patents)

14. Neil Brewis (2 out of 2 patents)

15. Sarka Pechouckova (2 out of 2 patents)

12 patents: Sort by Forward Citations

1. 12667573 - Compounds, compositions, and methods for the treatment of disease (2026-06-30),

2. 12534534 - ANTI-CD137 ANTIBODIES (2026-01-27),

3. 12390668 - Compounds, compositions, and methods for the treatment of disease (2025-08-19),

4. 12344672 - Antibody molecules that bind PD-L1 and CD137 (2025-07-01),

5. 12325742 - Anti-mesothelin antibodies (2025-06-10),

6. 12319739 - Mesothelin and CD137 binding molecules (2025-06-03),

7. 12297283 - Fc binding fragments comprising an OX40 antigen-binding site (2025-05-13),

8. 12252537 - Antibody molecules that bind CD137 and OX40 (2025-03-18),

9. 12247074 - Antibody molecules (2025-03-11),

10. 12187798 - LAG-3 binding members (2025-01-07),

11. 12187761 - Compounds, compositions, and methods for the treatment of disease (2025-01-07),

12. 12103976 - Fc binding fragments comprising a CD137 antigen-binding site (2024-10-01),

Invox Pharma Limited is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for patients with serious diseases. The company emphasizes the development of novel treatments aimed at addressing unmet medical needs in various therapeutic areas, including oncology and infectious diseases. With a commitment to research and development, Invox Pharma collaborates with leading scientific institutions and partners in the industry to advance their product candidates through the regulatory processes and into the marketplace. Their pipeline reflects a dedication to improving patient outcomes and quality of life through cutting-edge solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

12 Patents

#281 in London

#1,454 in United Kingdom

#48,055 in the World

London, United Kingdom

Invox Pharma Limited

Forward Citations = 4

35 inventors:

Mihriban Tuna (7 out of 14 patents)

Francisca Wollerton (5 out of 5 patents)

Miguel Gaspar (4 out of 6 patents)

4. Jose Munoz-Olaya (4 out of 4 patents)

5. Radhakrishnan P Iyer (3 out of 38 patents)

Please report any incorrect information to [email protected]

Loading…